Literature DB >> 8765019

Redirecting the complete T cell receptor/CD3 signaling machinery towards native antigen via modified T cell receptor.

T Brocker1, M Riedinger, K Karjalainen.   

Abstract

We show that a chimeric T cell receptor (TCR) beta chain consisting of a single-chain Fv portion derived from a monoclonal antibody and the full TCR beta chain is able to assemble functionally with endogenous TCR/CD3 components and transfer the antibody specificity as well as the TCR specificity into TCR beta- as well as into TCR beta+ T cells. This allows the incorporation new non-major histocompatibility complex-restricted ligand specificities into the intact TCR/CD3 complex which can exploit the full range of biological activities of the endogenous TCR signaling machinery. This approach can provide wider opportunities to redirect T cells to virus or tumor antigen-bearing cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8765019     DOI: 10.1002/eji.1830260816

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  2 in total

1.  Protein design of IgG/TCR chimeras for the co-expression of Fab-like moieties within bispecific antibodies.

Authors:  Xiufeng Wu; Arlene J Sereno; Flora Huang; Kai Zhang; Micheal Batt; Jonathan R Fitchett; Dongmei He; Heather L Rick; Elaine M Conner; Stephen J Demarest
Journal:  MAbs       Date:  2015       Impact factor: 5.857

Review 2.  Super-Treg: Toward a New Era of Adoptive Treg Therapy Enabled by Genetic Modifications.

Authors:  Leila Amini; Jenny Greig; Michael Schmueck-Henneresse; Hans-Dieter Volk; Séverine Bézie; Petra Reinke; Carole Guillonneau; Dimitrios L Wagner; Ignacio Anegon
Journal:  Front Immunol       Date:  2021-02-24       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.